Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • JBL vs GSK✓SelectedUSD · GSKJBL vs GSK performance historyLatest closeAs of-2.20%11/13
Stock and ETF performance explorer

JBL vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+1,148.2%
GSK return
+105.0%
Excess return
+1,043.3%
Maximum drawdown
-57.3%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 10y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-2.2%+0.5%-2.7%-2.3%
7D+6.3%+1.1%+5.2%+6.0%
30D-13.5%+6.3%-19.8%-15.3%
3M-31.3%+1.8%-33.1%-32.2%
6M-28.4%+1.7%-30.1%-29.7%
YTD+11.6%+6.5%+5.0%+7.2%
1Y+26.1%+9.5%+16.6%+20.0%
3Y+97.4%+65.3%+32.1%+51.4%
5Y+301.0%+43.7%+257.3%+222.9%
All+1,148.2%+105.0%+1,043.3%+701.3%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 10y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

10y analysis · Full analysis span regression · 6 months rolling